VVTMF (VVT Med) Debt-to-Asset : 1.41 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VVT Med Debt-to-Asset?

VVT Med VVTMF Debt-to-Asset is 1.41 as of Jun. 2026. The stock has 5 warning signs investors should review.

VVT Med's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $0.90 Mil. VVT Med's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $0.26 Mil. VVT Med's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was $0.83 Mil. VVT Med's debt to asset for the quarter that ended in Jun. 2026 was 1.41.

VVT Med  (OTCPK:VVTMF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

VVT Med Debt-to-Asset Related Terms

VVT Med Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for VVT Med's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med Debt-to-Asset Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
3.79 5.72 6.42 1.15

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.53 0.59 1.15 1.28 1.41

VVTMF vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, VVT Med's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VVT Med Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where VVT Med's Debt-to-Asset falls into.


VVT Med Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

VVT Med's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.811 + 0.245) / 0.916
=1.15

VVT Med's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.902 + 0.263) / 0.829
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 1.41 mean?
VVT Med (VVTMF) has a Debt-to-Asset of 1.41 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on VVT Med and its competitors.
Is VVT Med's Debt-to-Asset too high?
VVT Med's current Debt-to-Asset is 1.41.
How does VVT Med's Debt-to-Asset compare to ABT and SYK?
VVT Med's Debt-to-Asset of 1.41 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on VVT Med and its competitors. VVT Med's current Debt-to-Asset is 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Debt-to-Asset of 1.41. The current Debt-to-Asset is 1.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For VVT Med (VVTMF), the current Debt-to-Asset is 1.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.